169 related articles for article (PubMed ID: 11165141)
21. Delayed morbidity and mortality of albumin/SV40 T-antigen transgenic mice after insertion of an alpha-fetoprotein/herpes virus thymidine kinase transgene and treatment with ganciclovir.
Macri P; Gordon JW
Hum Gene Ther; 1994 Feb; 5(2):175-82. PubMed ID: 7514448
[TBL] [Abstract][Full Text] [Related]
22. Hypoxia/hepatoma dual specific suicide gene expression plasmid delivery using bio-reducible polymer for hepatocellular carcinoma therapy.
Kim HA; Nam K; Lee M; Kim SW
J Control Release; 2013 Oct; 171(1):1-10. PubMed ID: 23830978
[TBL] [Abstract][Full Text] [Related]
23. The targeted expression of the human interleukin-2/interferon alpha2b fused gene in alpha-fetoprotein-expressing hepatocellular carcinoma cells.
He P; Tang ZY; Liu BB; Ye SL; Liu YK
J Cancer Res Clin Oncol; 1999; 125(2):77-82. PubMed ID: 10190313
[TBL] [Abstract][Full Text] [Related]
24. Tissue-specific expression of HSV-tk gene can induce efficient antitumor effect and protective immunity to wild-type hepatocellular carcinoma.
Kuriyama S; Sakamoto T; Masui K; Nakatani T; Tominaga K; Kikukawa M; Yoshikawa M; Ikenaka K; Fukui H; Tsujii T
Int J Cancer; 1997 May; 71(3):470-5. PubMed ID: 9139886
[TBL] [Abstract][Full Text] [Related]
25. Utilizing alpha-fetoprotein expression to enhance oncolytic viral therapy in hepatocellular carcinoma.
Pin RH; Reinblatt M; Fong Y
Ann Surg; 2004 Oct; 240(4):659-65; discussion 665-6. PubMed ID: 15383793
[TBL] [Abstract][Full Text] [Related]
26. E1B-55K-deleted adenovirus expressing E1A-13S by AFP-enhancer/promoter is capable of highly specific replication in AFP-producing hepatocellular carcinoma and eradication of established tumor.
Takahashi M; Sato T; Sagawa T; Lu Y; Sato Y; Iyama S; Yamada Y; Fukaura J; Takahashi S; Miyanishi K; Yamashita T; Sasaki K; Kogawa K; Hamada H; Kato J; Niitsu Y
Mol Ther; 2002 May; 5(5 Pt 1):627-34. PubMed ID: 11991754
[TBL] [Abstract][Full Text] [Related]
27. The EIIAPA chimeric promoter for tumor specific gene therapy of hepatoma.
Hsieh YJ; Chen FD; Ke CC; Wang HE; Huang CJ; Hou MF; Lin KP; Gelovani JG; Liu RS
Mol Imaging Biol; 2012 Aug; 14(4):452-61. PubMed ID: 21796480
[TBL] [Abstract][Full Text] [Related]
28. Enhanced anti-tumor effects of herpes simplex virus thymidine kinase/ganciclovir system by codelivering monocyte chemoattractant protein-1 in hepatocellular carcinoma.
Sakai Y; Kaneko S; Nakamoto Y; Kagaya T; Mukaida N; Kobayashi K
Cancer Gene Ther; 2001 Oct; 8(10):695-704. PubMed ID: 11687892
[TBL] [Abstract][Full Text] [Related]
29. A novel tumor-specific replication-restricted adenoviral vector for gene therapy of hepatocellular carcinoma.
Hallenbeck PL; Chang YN; Hay C; Golightly D; Stewart D; Lin J; Phipps S; Chiang YL
Hum Gene Ther; 1999 Jul; 10(10):1721-33. PubMed ID: 10428217
[TBL] [Abstract][Full Text] [Related]
30. Selective inhibition of hepatoma cells using diphtheria toxin A under the control of the promoter/enhancer region of the human alpha-fetoprotein gene.
Kunitomi M; Takayama E; Suzuki S; Yasuda T; Tsutsui K; Nagaike K; Hiroi S; Tadakuma T
Jpn J Cancer Res; 2000 Mar; 91(3):343-50. PubMed ID: 10760695
[TBL] [Abstract][Full Text] [Related]
31. Cre/loxP system controlled by specific promoter for radiation-mediated gene therapy of hepatoma.
Hsieh YJ; Liu RS; Hwu L; Ke CC; Wang FH; Wang HE; Chen FD
Anticancer Res; 2007; 27(3B):1571-9. PubMed ID: 17595778
[TBL] [Abstract][Full Text] [Related]
32. An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 1. Flt3 ligand gene transfer increases antitumor effects of a radio-inducible suicide gene therapy in an ectopic tumor model.
Kawashita Y; Deb NJ; Garg M; Kabarriti R; Alfieri A; Takahashi M; Roy-Chowdhury J; Guha C
Radiat Res; 2014 Aug; 182(2):191-200. PubMed ID: 24972258
[TBL] [Abstract][Full Text] [Related]
33. Radioiodine gene therapy of hepatocellular carcinoma targeted human alpha fetoprotein.
Jin YN; Chung HK; Kang JH; Lee YJ; Kimm KI; Kim YJ; Kim S; Chung JK
Cancer Biother Radiopharm; 2008 Oct; 23(5):551-60. PubMed ID: 18986218
[TBL] [Abstract][Full Text] [Related]
34. An efficient and safe herpes simplex virus type 1 amplicon vector for transcriptionally targeted therapy of human hepatocellular carcinomas.
Lam PY; Sia KC; Khong JH; De Geest B; Lim KS; Ho IA; Wang GY; Miao LV; Huynh H; Hui KM
Mol Ther; 2007 Jun; 15(6):1129-36. PubMed ID: 17426711
[TBL] [Abstract][Full Text] [Related]
35. Hepatoma cell-specific expression of a retrovirally transferred gene is achieved by alpha-fetoprotein but not insulinlike growth factor II regulatory sequences.
Arbuthnot P; Bralet MP; Thomassin H; Danan JL; Bréchot C; Ferry N
Hepatology; 1995 Dec; 22(6):1788-96. PubMed ID: 7489990
[TBL] [Abstract][Full Text] [Related]
36. Targeting gene therapy for hepatocarcinoma cells with the E. coli purine nucleoside phosphorylase suicide gene system directed by a chimeric alpha-fetoprotein promoter.
Cai X; Zhou J; Chang Y; Sun X; Li P; Lin J
Cancer Lett; 2008 Jun; 264(1):71-82. PubMed ID: 18407409
[TBL] [Abstract][Full Text] [Related]
37. Cell-specific expression of artificial microRNAs targeting essential genes exhibit potent antitumor effect on hepatocellular carcinoma cells.
Mao C; Liu H; Chen P; Ye J; Teng L; Jia Z; Cao J
Oncotarget; 2015 Mar; 6(8):5707-19. PubMed ID: 25691059
[TBL] [Abstract][Full Text] [Related]
38. Selective targeting of genetically engineered mesenchymal stem cells to tumor stroma microenvironments using tissue-specific suicide gene expression suppresses growth of hepatocellular carcinoma.
Niess H; Bao Q; Conrad C; Zischek C; Notohamiprodjo M; Schwab F; Schwarz B; Huss R; Jauch KW; Nelson PJ; Bruns CJ
Ann Surg; 2011 Nov; 254(5):767-74; discussion 774-5. PubMed ID: 22042469
[TBL] [Abstract][Full Text] [Related]
39. Hepatoma cell-specific ganciclovir-mediated toxicity of a lentivirally transduced HSV-TkEGFP fusion protein gene placed under the control of rat alpha-fetoprotein gene regulatory sequences.
Uch R; Gérolami R; Faivre J; Hardwigsen J; Mathieu S; Mannoni P; Bagnis C
Cancer Gene Ther; 2003 Sep; 10(9):689-95. PubMed ID: 12944988
[TBL] [Abstract][Full Text] [Related]
40. Gene therapy vectors harboring AFP regulatory sequences. Preparation of an adenoviral vector.
Kaneko S; Tamaoki T
Mol Biotechnol; 2001 Nov; 19(3):323-30. PubMed ID: 11721628
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]